Figure 9
From: Precision medicine for suicidality: from universality to subtypes and personalization
Universal biomarkers—convergent functional evidence (CFE) for involvement in suicidality. Top Dozen and Bonferroni biomarkers. Post-hoc summation of all the evidence form discovery, validation, prioritization and testing (for state—SI and for trait-future hospitalizations), along with evidence for involvement in other psychiatric disorders and for being a target of drugs. This prioritization highlights for future studies biomarkers that may have broad applicability in the field, for diagnostics and therapeutics. ASD, autism spectrum disorder; BP, bipolar; MDD, major depressive disorder; PTSD, post-traumatic stress disorder; SZ, schizophrenia.
